Liang Jin

1.2k total citations
32 papers, 822 citations indexed

About

Liang Jin is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Liang Jin has authored 32 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 13 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Liang Jin's work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (10 papers) and Advanced Breast Cancer Therapies (8 papers). Liang Jin is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (10 papers) and Advanced Breast Cancer Therapies (8 papers). Liang Jin collaborates with scholars based in China, United States and Israel. Liang Jin's co-authors include Erwei Song, Fengxi Su, Qiang Liu, Yujie Liu, Shunying Li, Weijuan Jia, Shunrong Li, Jieqiong Liu, Herui Yao and Qianfeng Shi and has published in prestigious journals such as Nature Communications, Cancer Research and Diabetes.

In The Last Decade

Liang Jin

30 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang Jin China 15 413 344 342 166 140 32 822
Huawei Zou China 16 322 0.8× 403 1.2× 244 0.7× 163 1.0× 70 0.5× 36 710
Jin He China 16 356 0.9× 570 1.7× 167 0.5× 98 0.6× 110 0.8× 47 907
Elisabetta Zulato Italy 16 492 1.2× 600 1.7× 342 1.0× 266 1.6× 93 0.7× 37 1.0k
Emanuele Valtorta Italy 16 357 0.9× 531 1.5× 661 1.9× 331 2.0× 258 1.8× 40 1.2k
Francisco Beça United States 16 353 0.9× 383 1.1× 321 0.9× 120 0.7× 125 0.9× 33 829
Helen Cawley United States 11 211 0.5× 366 1.1× 487 1.4× 149 0.9× 96 0.7× 16 812
Sara E. Bellomo Italy 9 322 0.8× 282 0.8× 509 1.5× 135 0.8× 196 1.4× 19 797
Dakui Luo China 15 468 1.1× 479 1.4× 268 0.8× 129 0.8× 64 0.5× 48 877
Chundong Gu China 20 238 0.6× 535 1.6× 299 0.9× 357 2.2× 97 0.7× 51 1.0k
David Cordero Spain 14 232 0.6× 392 1.1× 242 0.7× 223 1.3× 197 1.4× 23 728

Countries citing papers authored by Liang Jin

Since Specialization
Citations

This map shows the geographic impact of Liang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Jin more than expected).

Fields of papers citing papers by Liang Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Jin. The network helps show where Liang Jin may publish in the future.

Co-authorship network of co-authors of Liang Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Jin. A scholar is included among the top collaborators of Liang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Jin. Liang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jin, Liang, et al.. (2024). The association of preoperative serum free fatty acid levels with survival in breast cancer patients. Discover Oncology. 15(1). 629–629. 1 indexed citations
3.
Cai, Zijie, Liang Jin, Shunying Li, et al.. (2023). LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein. Science Advances. 9(40). eadi3821–eadi3821. 18 indexed citations
4.
Zhao, Xin, Liang Jin, Yujie Liu, Zhenzhen Liu, & Qiang Liu. (2022). Bioinformatic analysis of the role of solute carrier-glutamine transporters in breast cancer. Annals of Translational Medicine. 10(14). 777–777. 9 indexed citations
5.
Yang, Yaping, Weidong Wei, Liang Jin, et al.. (2022). Comparison of the Characteristics and Prognosis Between Very Young Women and Older Women With Breast Cancer: A Multi-Institutional Report From China. Frontiers in Oncology. 12. 783487–783487. 15 indexed citations
6.
7.
Jin, Liang, Kai Chen, Cui Tan, et al.. (2020). Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer. The Oncologist. 25(8). e1170–e1180. 6 indexed citations
8.
Shi, Qianfeng, Yudong Li, Shunying Li, et al.. (2020). LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nature Communications. 11(1). 5513–5513. 149 indexed citations
9.
10.
Li, Jingjing, Jing Zhang, Liang Jin, Heran Deng, & Jiannan Wu. (2018). Silencinglnc-ASAH2B-2Inhibits Breast Cancer Cell Growthviathe mTOR Pathway. Anticancer Research. 38(6). 3427–3434. 9 indexed citations
11.
Zhu, Yinghua, Yujie Liu, Chao Zhang, et al.. (2018). Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. Nature Communications. 9(1). 1595–1595. 110 indexed citations
12.
Hu, Yue, Ran Gu, Jinghua Zhao, et al.. (2017). Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2− breast cancers by the 2015 St. Gallen consensus classification. BMC Cancer. 17(1). 28–28. 7 indexed citations
13.
Jin, Liang, Liling Zhu, Shunrong Li, et al.. (2017). Predictors of Malignancy for Female Patients with Suspicious Nipple Discharge: A Retrospective Study. Anticancer Research. 37(8). 4655–4658. 4 indexed citations
14.
Jia, Haixia, Weijuan Jia, Yaping Yang, et al.. (2014). HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World Journal of Surgical Oncology. 12(1). 289–289. 20 indexed citations
15.
Zhu, Liling, Liang Jin, Shunrong Li, et al.. (2013). Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis. Breast Cancer Research and Treatment. 137(3). 783–795. 50 indexed citations
16.
Liu, Jieqiong, Heran Deng, Weijuan Jia, et al.. (2012). Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment. Journal of Cancer Research and Clinical Oncology. 138(5). 837–842. 20 indexed citations
17.
18.
Li, Shunrong, Jiannan Wu, Kai Chen, et al.. (2012). Clinical outcomes of 1,578 Chinese patients with breast benign diseases after ultrasound-guided vacuum-assisted excision: recurrence and the risk factors. The American Journal of Surgery. 205(1). 39–44. 16 indexed citations
19.
Chen, Kai, Weijuan Jia, Shunrong Li, et al.. (2011). Cavity Margin Status Is an Independent Risk Factor for Local-Regional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Before Breast-Conserving Surgery. The American Surgeon. 77(12). 1700–1706. 9 indexed citations
20.
Deng, Heran, Lun Chen, Weijuan Jia, et al.. (2011). Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients. Journal of Cancer Research and Clinical Oncology. 137(12). 1869–1874. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huawei Zou Breakdown of academic impact, for papers by Jin He Breakdown of academic impact, for papers by Elisabetta Zulato Breakdown of academic impact, for papers by Emanuele Valtorta Breakdown of academic impact, for papers by Francisco Beça Breakdown of academic impact, for papers by Helen Cawley Breakdown of academic impact, for papers by Sara E. Bellomo Breakdown of academic impact, for papers by Dakui Luo Breakdown of academic impact, for papers by Chundong Gu Breakdown of academic impact, for papers by David Cordero
Rankless by CCL
2026